Molecular elucidation of the Francisella tularensis virulence mechanism
土拉弗朗西斯菌毒力机制的分子阐明
基本信息
- 批准号:10408864
- 负责人:
- 金额:$ 79.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-21 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AerosolsAffinityAutomobile DrivingBacteriaBindingBiochemicalBiological AssayBlood capillariesC-terminalCategoriesCellsComplexCryoelectron MicroscopyCrystallizationDNADNA BindingDNA StructureDNA-Binding ProteinsDangerousnessDataDevelopmentDisease OutbreaksDissectionDrug DesignDrug TargetingElementsFluorescence PolarizationFrancisellaFrancisella tularensisGene ExpressionGenesGoalsGovernmentGrowthGuanosine TetraphosphateHelix-Turn-Helix MotifsHeterodimerizationHoloenzymesLigandsMediatingMedical centerMolecularMorbidity - disease ratePathogenesisPathogenicityPathogenicity IslandPeptidesPolymeraseProteinsRadialRegulationRegulator GenesRegulonResearchResolutionSignal TransductionSiteStarvationStructureTailTestingTherapeuticTranscriptional ActivationTranscriptional RegulationTularemiaVirulenceWinged Helixaerosolizedbasebioweaponimprovedin vivoinhibitormacrophagemortalitynew therapeutic targetnovelnovel therapeuticspathogenic bacteriapreventpromoterprotein expressionrational designrecruittranscriptome sequencing
项目摘要
Francisella tularensis (Ft), the causative agent of tularemia, is one of the most infectious bacterial pathogens
known. Due to its high infectivity and ease of aerosolization, it has been classified as Category A bioweapon by
the US government. The morbidity and mortality of tularemia are substantial, and given its extreme infectivity, a
significant outbreak of tularemia would readily overwhelm the capabilities of even the largest US medical
centers. Ft virulence requires genes expressed from the chromosomally encoded Ft pathogenicity island (FPI).
The expression of these genes are activated by a combination of Ft regulators: the stringent starvation protein
A (SspA), the macrophage growth locus protein A (MglA) and the pathogenicity island gene regulator (PigR),
which are expressed during Ft infection. MglA and PigR are unique to Ft whereas SspA proteins are found in
multiple bacteria. The Ft SspA, however, is unusual as it does not homodimerize but rather heterodimerizes
with MglA. PigR is a DNA-binding protein with a predicted winged-helix-turn-helix DNA-binding motif.
Intriguingly, the “alarmone”, guanosine tetraphosphate (ppGpp), is also necessary for Ft virulence. Recently,
we showed that this alarmone binds directly to the MglA-SspA complex. We further showed that ppGpp binding
to MglA-SspA mediates high-affinity binding of PigR to this heterodimer. Strikingly, our data also revealed that
MglA-SspA interacts constitutively with the Ft RNAPs70 holoenzyme suggesting it represents a virulence
specialized RNAP. Given the extreme virulence and potential use of Ft as a bioweapon, there is an urgent
need to decipher the molecular mechanisms driving its virulence. The overarching goal of this proposal is the
molecular dissection of these mechanisms. Our central hypothesis is that Ft employs a conceptually novel form
of pathogenesis requiring a virulence-specialized RNAP containing MglA-SspA. We shall test our central
hypothesis and delineate the molecular mechanisms controlling the activation of Ft virulence genes through
the completion of three Specific Aims: Specific Aim 1: To fully characterize MglA-SspA interaction with Ft
RNAP. Structural, biochemical and cellular studies will dissect the mechanism of virulence regulation by MglA-
SspA. Specific Aim 2: To carry out structure and function analyses of Ft RNAP(MglA-SspA)-ppGpp-PigR
complexes. The mechanism behind PigR-mediated activation of the FPI will be analyzed structurally,
biochemically and in vivo. Specific Aim 3: To determine a high resolution (MglA-SspA)-ppGpp-PigR crystal
structure, identify inhibitors of ppGpp binding to MglA-SspA and obtain structures of MglA-SspA inhibitor
complexes. The successful completion of these Aims will reveal new paradigms in transcription regulation and
enable the rational design of novel anti Francisella-virulence therapeutics.
francisella tularensis(ft)是tularemia的致病药物,是最感染性细菌病原体之一
已知。由于其高感染和易于气化,因此已将其归类为生物武器类别
美国政府。 t骨的发病率和死亡率是实质的,鉴于其极端的感染,
大量爆发tularemia很容易使美国医学最大的医学的能力不堪重负
中心。 FT病毒需要从染色体编码的FT致病岛(FPI)表达的基因。
这些基因的表达是通过FT调节剂的组合激活的:严格的饥饿蛋白
A(SSPA),巨噬细胞生长基因座蛋白A(MGLA)和致病性岛基因调节剂(PIGR),
在英尺感染期间表达。 MGLA和PIGR是FT独有的,而SSPA蛋白在
多种细菌。但是,FT SSPA是不寻常的
与mgla。 PIGR是一种DNA结合蛋白,具有预测的翼螺旋 - 螺旋螺旋DNA结合基序。
有趣的是,“警报器”,四磷酸鸟嘌呤四磷酸(PPGPP)也是FT病毒所必需的。最近,
我们表明该警报器直接与MGLA-SSPA复合物结合。我们进一步表明PPGPP结合
为了MGLA-SPA介导PIGR与该异二聚体的高亲和力结合。令人惊讶的是,我们的数据还显示
MGLA-SPA与FT RNAPS70全酶组成构成相互作用,表明它代表了病毒
专门的RNAP。考虑到FT作为生物武器的极端病毒和潜在用途,有一个紧急的
需要破译驱动其病毒的分子机制。该提议的总体目标是
这些机制的分子解剖。我们的中心假设是,英尺雇员在概念上新颖的形式
需要病毒特异性RNAP的发病机理。我们将测试我们的中央
假设并描述控制FT病毒基因激活的分子机制
完成三个特定目的的完成:特定目标1:完全表征与ft的MGLA-SSPA相互作用
rnap。结构,生化和细胞研究将剖析MGLA-的病毒调节机制
SSPA。特定目标2:进行FT RNAP(MGLA-SSPA)-PPGPP-PIGR的结构和功能分析
复合物。 PIGR介导的FPI激活背后的机制将在结构上分析,
生化和体内。特定目标3:确定高分辨率(MGLA-SSPA)-PPGPP-PIGR晶体
结构,鉴定PPGPP与MGLA-SSPA结合的抑制剂,并获得MGLA-SSPA抑制剂的结构
复合物。这些目标的成功完成将揭示转录法规中的新范式,
启用新型抗Francisella病毒疗法的合理设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD GERALD BRENNAN其他文献
RICHARD GERALD BRENNAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD GERALD BRENNAN', 18)}}的其他基金
Molecular elucidation of the Francisella tularensis virulence mechanism
土拉弗朗西斯菌毒力机制的分子阐明
- 批准号:
10242477 - 财政年份:2021
- 资助金额:
$ 79.71万 - 项目类别:
Molecular elucidation of the Francisella tularensis virulence mechanism
土拉弗朗西斯菌毒力机制的分子阐明
- 批准号:
10611505 - 财政年份:2021
- 资助金额:
$ 79.71万 - 项目类别:
Structural Elucidation of the Novel RNA Polymerase Underlying Francisella Tularensis Virulence
土拉弗朗西斯菌毒力背后的新型 RNA 聚合酶的结构解析
- 批准号:
10089396 - 财政年份:2020
- 资助金额:
$ 79.71万 - 项目类别:
Structural Elucidation of the Novel RNA Polymerase Underlying Francisella Tularensis Virulence
土拉弗朗西斯菌毒力背后的新型 RNA 聚合酶的结构解析
- 批准号:
9977601 - 财政年份:2020
- 资助金额:
$ 79.71万 - 项目类别:
Defining the structural mechanisms of Hfq binding to cognate nucleic acids
定义 Hfq 与同源核酸结合的结构机制
- 批准号:
9094550 - 财政年份:2015
- 资助金额:
$ 79.71万 - 项目类别:
Trehalose Pathway for Antifungal Targets and Inhibitors
抗真菌靶点和抑制剂的海藻糖途径
- 批准号:
8931205 - 财政年份:2015
- 资助金额:
$ 79.71万 - 项目类别:
Defining the structural mechanisms of Hfq binding to cognate nucleic acids
定义 Hfq 与同源核酸结合的结构机制
- 批准号:
8809577 - 财政年份:2015
- 资助金额:
$ 79.71万 - 项目类别:
STRUCTURAL MECHANISM OF THE T GONDII UPRT, A TARGET FOR STRUCTURAL-BASED DRUG D
T GONDII UPRT 的结构机制,基于结构的药物 D 的靶标
- 批准号:
7721784 - 财政年份:2008
- 资助金额:
$ 79.71万 - 项目类别:
CRYSTALLOGRAPHIC STUDIES OF GLUTAMINE SYNTHETASE AND TNRA FROM BACILLUS SUBTILIS
枯草芽孢杆菌谷氨酰胺合成酶和 TNRA 的晶体学研究
- 批准号:
7721786 - 财政年份:2008
- 资助金额:
$ 79.71万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Molecular elucidation of the Francisella tularensis virulence mechanism
土拉弗朗西斯菌毒力机制的分子阐明
- 批准号:
10242477 - 财政年份:2021
- 资助金额:
$ 79.71万 - 项目类别: